In this article from November 2019, Cardiff University’s School of Pharmacy and Pharmaceutical Sciences describes the early stages of their research to find a way to deliver a chemical product that bypasses the faulty enzyme caused by a mutation in the GNE gene and re-estblish the body’s production of sialic acid.

Read the full story from Cardiff University and access the research here.